05242017Headline:

Lansing, Michigan

HomeMichiganLansing

Email David Mittleman David Mittleman on LinkedIn David Mittleman on Facebook David Mittleman on Avvo
David Mittleman
David Mittleman
Attorney • (888) 227-4770

Generic Drugs Not Always as Safe or Effective as Name Brand

1 comment

Generic Drugs Not Always the Same as Name Brand

Generic drugs often seem like the perfect choice: they allow the patient to get their medication for a fraction of the cost compared to name brand alternatives.  However, what you might not realize is that generic drugs aren’t always the same as name brand drugs.  This is largely because the Food and Drug Administration requires generic drug manufacturers to include the same labeling on their products as that on the name brand version, even if the generic manufacturer knows the labeling to be out of date or incorrect.  Furthermore, not all generic drugs are made equal to the name brand counterparts.  Clearly, this could spell big problems for patients whose medication is a matter of life or death.

Food and Drug Administration Proposes Change to Labeling Rules

Currently, generic drugs account for over 80% of drugs prescribed today.  More generic drugs may be manufactured overseas, in places such as India or China, where the FDA’s oversight does not reach.  Consequently, the FDA is proposing to require generic manufacturers to immediately update labels to reflect the latest safety information on a drug.  The other problem, however, is that patients have no legal recourse if they are injured or killed as a result of taking a faulty generic drug, thanks to a recent U.S. Supreme Court decision.  On the other hand, if a patient takes a more expensive name brand drug, then their legal recourse is preserved.

Advocates Step Up for Patients

Advocates from the Center for Justice & Democracy are stepping up for patients’ rights, especially because patients don’t always have a choice between a name brand or generic prescription drug.  Commonly, the doctor decides which to prescribe, leaving patients vulnerable to both doctors’ decisions and the generic drug industry’s lack of oversight.  The Center is happy that the FDA has made some steps in the right direction as far as the safety of generic drug labeling, but much more needs to occur before patients are fully protected–including the ability to seek legal recourse if they harmed by a generic drug.

1 Comment

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

  1. up arrow

    I am amazed at how few people know that they are in fact giving up their legal rights when they chose a generic version of this drug. I hope this won’t always be the case, but until the public is fully aware I am glad you are taking time to warn them! Great post.